Showing 361-370 of 7496 results for "".
5 Year Plan: Innovation Update
https://practicaldermatology.com/conferences/asds-2021/5-year-plan-innovation-update/20024/Mat Avram, MD provides an update on newly approved technologies as well as some that could be in use in practice within the next five years to improve outcomes or increase safety.Understanding the Complex Circuitry of Inflammatory Cytokines That Contribute to Psoriasis Pathogenesis
https://practicaldermatology.com/topics/psoriasis/understanding-the-complex-circuitry-of-inflammatory-cytokines-that-contribute-to-psoriasis-pathogenesis/19944/Hear expert insights on the mechanism of disease to understand the intricate circuitry of inflammatory cytokines in psoriasis pathogenesis.SARS-CoV-2 and the Skin: Inside the COVID-19 Dermatology Registry
https://practicaldermatology.com/conferences/aad-2021/sars-cov-2-and-the-skin-inside-the-covid-19-dermatology-registry/19921/From COVID Toes to COVID Arms, dermatologic manifestations of SARS-CoV-2 infection and COVID-19 vaccination abound. Esther Freeman, MD, PhD, Director of the COVID-19 Dermatology Registry provides an overview of findings and shares information about the relatively new vaccine registry.Seeing the Individual in AD Care
https://practicaldermatology.com/topics/atopic-dermatitis/seeing-the-individual-in-ad-care/19890/The best care for patients with atopic dermatitis requires a holistic approach, suggests Dr. Stephan Weidinger. He discusses strategies to improve the management of this complex diseases and highlights innovative strategies for care identified through the Quality of Care in Atopic Dermatitis initiatLong-term efficacy and safety data from ILUMYA™ clinical trials
https://practicaldermatology.com/topics/psoriasis/long-term-efficacy-and-safety-data-from-ilumya-clinical-trials/19858/Explore efficacy and safety data for ILUMYA™ from the reSURFACE 1 and reSURFACE 2 Phase 3 trials and extension studies.Why your dermatology practice isn’t ranking well on Google
https://practicaldermatology.com/topics/practice-management/why-your-dermatology-practice-isnt-ranking-well-on-google/19647/If your dermatology website isn’t ranking well on Google, there are hundreds of possible reasons why. However, in many cases the answer is quite simple. This Ekwa Marketing video explains some of the most common mistakes, and what to do about them.Private Equity in Dermatology: An Inside View
https://practicaldermatology.com/topics/practice-management/private-equity-in-dermatology-an-inside-view/18219/Private equity firms are turning their attention to the dermatology specialty. Why? How has the market changed and what may be on the horizon? An investment banker with knowledge of the field weighs in with an overview from him perspective.Behind the Scenes: Preparing to Inject
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aad-orlando-daily-coverage-day---wvpotpwa/18529/Live injection sessions are a great way to learn techniques and review injection anatomy for best outcomes and patient safety. Doris Day, MD speaks about these issues and shares her perspective on preparing to inject for these sessions.What is the most important thing you do every morning?
https://practicaldermatology.com/topics/practice-management/what-is-the-most-important-thing-you-do-every-morning/18566/Adam Friedman, MD shares what he does every morning to set the tone and mentally prepare for the day. Watch other PD Asks videos with Adam Friedman, MD, FAAD: In a movie about your practice, who would play you? What is the best "prop" or fixture in your exam rooms that facilitates patient interaDifferin Goes OTC, ISDIN Comes to America, Understand AD
https://practicaldermatology.com/topics/psoriasis/dermwiretv-differin-goes-otc-isdin-comes-to-america-understand-ad/18762/Barcelona-based ISDIN is officially operating in the US. The company—which operates in Europe, Latin America, and Asia—is bringing its skincare products to the US market. Regeneron Pharmaceuticals, Sanofi Genzyme, the National Eczema Association, and the Dermatology Nurses Association launch Under